AMBER ATKINSON: Open Payments
NPI 1417309147 · CARTHAGE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 37 payments from 13 companies in 2025. Trend: 2023 $635 · 2024 $560 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $245 |
| Verona Pharma, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $56 |
| Novo Nordisk Inc | 3 | $53 |
| Averitas Pharma Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| PFIZER INC. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 3 | $25 |
| Abbott Laboratories | 1 | $22 |
Products named: BREZTRI, FARXIGA, Ohtuvayre, Ozempic, QUTENZA, AIRSUPRA, LINZESS, Auvelity.
Industry payments across MS — which companies pay providers there.
